"Designing Growth Strategies is in our DNA"

U.S. Heparin Market Size, Share, Analysis, By Product (Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH)), By Source (Bovine and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion and Subcutaneous Injection), and By End-user (Hospitals & ASCs, Clinics, and Others), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108746

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Cardiovascular Diseases in the U.S.
    2. Blood Clots: Stats & Facts
    3. Overview of Technological Advancements in Heparin
    4. New Product Launches, By Key Players
    5. Key Industry Development: Mergers, Acquisitions, and Partnerships
    6. Regulatory Scenario
    7. Reimbursement Scenario
    8. Impact of COVID-19 on the Market
  5. U.S. Heparin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Fresenius SE & Co. KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. B. Braun SE
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Sagent Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Mylan N.V.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Baxter
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Amphastar Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Scientific Protein Laboratories
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Cardiovascular Diseases in the U.S.
    2. Blood Clots: Stats & Facts
    3. Overview of Technological Advancements in Heparin
    4. New Product Launches, By Key Players
    5. Key Industry Development: Mergers, Acquisitions, and Partnerships
    6. Regulatory Scenario
    7. Reimbursement Scenario
    8. Impact of COVID-19 on the Market
  5. U.S. Heparin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Fresenius SE & Co. KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. B. Braun SE
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Sagent Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Mylan N.V.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Baxter
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Amphastar Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Scientific Protein Laboratories
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Heparin Market Revenue Breakdown (USD billion, %), By Product, 2024 & 2032

Figure 2:  U.S. Heparin Market Value Share (%), by Product, 2024 & 2032

Figure 3:  U.S. Heparin Market Value Share (%), by Source, 2024 & 2032

Figure 4:  U.S. Heparin Market Value Share (%), by Application, 2024 & 2032

Figure 5:  U.S. Heparin Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 6:  U.S. Heparin Market Value Share (%), by End User, 2024 & 2032

Figure 7:  U.S. Heparin Market Share (%), By Company, 2023

Table 1:  U.S. Heparin Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 2:  U.S. Heparin Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 3:  U.S. Heparin Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 4:  U.S. Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 5:  U.S. Heparin Market Revenue (USD billion) Forecast, by End User, 2019–2032

U.S. Heparin Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 90
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports